News on Tracleer from BioPortfolio.com http://www.BioPortfolio.com Consolidated Tracleer news from BioPortfolio.com Tue, 09 Feb 2010 22:49:29 GMT en Pirfenidone Panel, Tracleer Data to Start IPF Pot Boilinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031344&HITNO=0&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031344&THISHREF=http://c.moreover.com/click/here.pl%3fz2534144976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031344&HITNO=0&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031344&THISHREF=http://c.moreover.com/click/here.pl%3fz2534144976%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: Pirfenidone Panel, Tracleer Data to Start IPF Pot Boilinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027774&HITNO=1&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027774&THISHREF=http://c.moreover.com/click/here.pl%3fz2532338599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027774&HITNO=1&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027774&THISHREF=http://c.moreover.com/click/here.pl%3fz2532338599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld Financial Watch: Actelion Pharmaceuticals Ltd (CH) - Actelion to Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024881&HITNO=2&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024881&THISHREF=http://c.moreover.com/click/here.pl%3fz2529256857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024881&HITNO=2&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024881&THISHREF=http://c.moreover.com/click/here.pl%3fz2529256857%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: UPDATE 2-US FDA panel backs new use for Actelion drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897687&HITNO=3&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897687&THISHREF=http://c.moreover.com/click/here.pl%3fz2462375405%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897687&HITNO=3&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897687&THISHREF=http://c.moreover.com/click/here.pl%3fz2462375405%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: UPDATE 2-US FDA panel backs new use for Actelion drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897506&HITNO=4&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897506&THISHREF=http://c.moreover.com/click/here.pl%3fz2462270745%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897506&HITNO=4&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897506&THISHREF=http://c.moreover.com/click/here.pl%3fz2462270745%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: UPDATE 2-US FDA panel backs new use for Actelion drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897478&HITNO=5&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897478&THISHREF=http://c.moreover.com/click/here.pl%3fz2462255566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897478&HITNO=5&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897478&THISHREF=http://c.moreover.com/click/here.pl%3fz2462255566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Actelion Pharmaceuticals Ltd (ch) - Actelion to Present at the 28th Annual J.P. Morgan Healthcare Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891531&HITNO=6&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891531&THISHREF=http://c.moreover.com/click/here.pl%3fz2459758181%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891531&HITNO=6&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891531&THISHREF=http://c.moreover.com/click/here.pl%3fz2459758181%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: US FDA questions Actelion rare disease drug datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880564&HITNO=7&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880564&THISHREF=http://c.moreover.com/click/here.pl%3fz2453456722%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880564&HITNO=7&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880564&THISHREF=http://c.moreover.com/click/here.pl%3fz2453456722%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters Health: UPDATE 2-US FDA questions Actelion rare disease drug datahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878738&HITNO=8&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878738&THISHREF=http://c.moreover.com/click/here.pl%3fz2452383897%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878738&HITNO=8&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878738&THISHREF=http://c.moreover.com/click/here.pl%3fz2452383897%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: Safety worries hit Actelion's key sleep drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3816863&HITNO=9&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3816863&THISHREF=http://c.moreover.com/click/here.pl%3fz2417706952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3816863&HITNO=9&MSIZE=10&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Tracleer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3816863&THISHREF=http://c.moreover.com/click/here.pl%3fz2417706952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters Health: